Carlyle Group (CG)
(Real Time Quote from BATS)
$39.67 USD
-0.41 (-1.02%)
Updated Aug 30, 2024 01:54 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Carlyle Group (CG) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$47.00 | $64.00 | $32.00 | 17.27% |
Price Target
Based on short-term price targets offered by 15 analysts, the average price target for Carlyle Group comes to $47.00. The forecasts range from a low of $32.00 to a high of $64.00. The average price target represents an increase of 17.27% from the last closing price of $40.08.
Analyst Price Targets (15)
Broker Rating
Carlyle Group currently has an average brokerage recommendation (ABR) of 2.31 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 16 brokerage firms. The current ABR compares to an ABR of 2.27 a month ago based on 15 recommendations.
Of the 16 recommendations deriving the current ABR, six are Strong Buy, representing 37.5% of all recommendations. A month ago, Strong Buy represented 40%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/CG.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 5 | 6 | 6 | 6 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 9 | 9 | 8 | 8 | 8 |
Sell | 1 | 0 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.31 | 2.29 | 2.27 | 2.27 | 2.27 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/27/2024 | Atlantic Equities | Nicholas Watts | Not Available | Strong Buy |
8/13/2024 | Not Identified | Not Identified | Hold | Hold |
8/6/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/6/2024 | Evercore Partners | Glenn P Schorr | Hold | Hold |
8/6/2024 | Keefe Bruyette & Woods | Kyle K Voigt | Hold | Hold |
8/5/2024 | Not Identified | Not Identified | Hold | Hold |
7/22/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/2/2024 | Goldman Sachs | Alexander Blostein | Strong Buy | Strong Buy |
4/12/2024 | UBS | Adam Q Beatty | Hold | Hold |
4/1/2024 | Cowen & Co. | William R Katz | Hold | Hold |
2/8/2024 | JMP Securities | Devin Ryan | Strong Buy | Strong Buy |
2/8/2024 | Not Identified | Not Identified | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.31 |
ABR (Last week) | 2.29 |
# of Recs in ABR | 16 |
Average Target Price | $47.00 |
LT Growth Rate | 8.90% |
Industry | Financial - Investment Funds |
Industry Rank by ABR | 31 of 253 |
Current Quarter EPS Est: | 0.94 |